ROS-responsive nanogels enable inhaled CD24 immunotherapy for selective hyperinflammation suppression in severe pneumonia

Xin Wang, Xiaofei Zhao, Fan Zhang, Siyu Wang, Fenghua Meng, Chao Deng, Mingzhou Ye, Zhiyuan Zhong

Open source

DOI
10.1126/sciadv.aec3712
Published
2026-08-21
Container
Science Advances
Publisher
American Association for the Advancement of Science (AAAS)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1126/sciadv.aec3712,
  title = {ROS-responsive nanogels enable inhaled CD24 immunotherapy for selective hyperinflammation suppression in severe pneumonia},
  author = {Xin Wang and Xiaofei Zhao and Fan Zhang and Siyu Wang and Fenghua Meng and Chao Deng and Mingzhou Ye and Zhiyuan Zhong},
  year = {2026},
  journal = {Science Advances},
  doi = {10.1126/sciadv.aec3712},
  url = {https://doi.org/10.1126/sciadv.aec3712}
}

RIS

TY  - JOUR
TI  - ROS-responsive nanogels enable inhaled CD24 immunotherapy for selective hyperinflammation suppression in severe pneumonia
AU  - Xin Wang
AU  - Xiaofei Zhao
AU  - Fan Zhang
AU  - Siyu Wang
AU  - Fenghua Meng
AU  - Chao Deng
AU  - Mingzhou Ye
AU  - Zhiyuan Zhong
PY  - 2026
JO  - Science Advances
DO  - 10.1126/sciadv.aec3712
UR  - https://doi.org/10.1126/sciadv.aec3712
ER  - 

APA

Wang, X., Zhao, X., Zhang, F., Wang, S., Meng, F., Deng, C., Ye, M., & Zhong, Z. (2026). ROS-responsive nanogels enable inhaled CD24 immunotherapy for selective hyperinflammation suppression in severe pneumonia. Science Advances. https://doi.org/10.1126/sciadv.aec3712

Source records